Free Trial
NASDAQ:SYRA

Syra Health (SYRA) Stock Price, News & Analysis

Syra Health logo
$0.31 +0.00 (+1.63%)
Closing price 03/27/2025 03:50 PM Eastern
Extended Trading
$0.31 0.00 (-0.13%)
As of 03/27/2025 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Syra Health Stock (NASDAQ:SYRA)

Key Stats

Today's Range
$0.29
$0.31
50-Day Range
$0.30
$0.55
52-Week Range
$0.20
$2.27
Volume
74,984 shs
Average Volume
760,939 shs
Market Capitalization
$3.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.

Remove Ads

Syra Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

SYRA MarketRank™: 

Syra Health scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Syra Health.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Syra Health is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Syra Health is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Syra Health has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Syra Health's valuation and earnings.
  • Percentage of Shares Shorted

    7.45% of the float of Syra Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Syra Health has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Syra Health has recently decreased by 16.37%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Syra Health does not currently pay a dividend.

  • Dividend Growth

    Syra Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.45% of the float of Syra Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Syra Health has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Syra Health has recently decreased by 16.37%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Syra Health has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Syra Health this week, compared to 6 articles on an average week.
  • Search Interest

    3 people have searched for SYRA on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Syra Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.18% of the stock of Syra Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.75% of the stock of Syra Health is held by institutions.

  • Read more about Syra Health's insider trading history.
Receive SYRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syra Health and its competitors with MarketBeat's FREE daily newsletter.

SYRA Stock News Headlines

A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....
Syra Health Corp Class A Common Stock
See More Headlines

SYRA Stock Analysis - Frequently Asked Questions

Syra Health's stock was trading at $0.4119 at the beginning of 2025. Since then, SYRA stock has decreased by 25.6% and is now trading at $0.3064.
View the best growth stocks for 2025 here
.

Syra Health Corp. (NASDAQ:SYRA) released its quarterly earnings results on Tuesday, March, 11th. The company reported ($0.05) earnings per share for the quarter. The firm earned $2 million during the quarter, compared to analyst estimates of $2.01 million. Syra Health had a negative net margin of 54.90% and a negative trailing twelve-month return on equity of 131.94%.

Syra Health (SYRA) raised $7 million in an initial public offering on Friday, September 29th 2023. The company issued 1,600,000 shares at $4.13 per share. Kingswood served as the underwriter for the IPO.

Top institutional investors of Syra Health include Warberg Asset Management LLC (0.88%). Insiders that own company stock include Priya Prasad, Sandeep Allam, Feroz Syed and Deepika Vuppalanchi.
View institutional ownership trends
.

Shares of SYRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Syra Health investors own include American Airlines Group (AAL), Meta Platforms (META), PACCAR (PCAR), Super Micro Computer (SMCI), Arista Networks (ANET), Darden Restaurants (DRI) and Fabrinet (FN).

Company Calendar

Last Earnings
3/11/2025
Today
3/27/2025
Next Earnings (Estimated)
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Employment agencies
Sub-Industry
Business Services
Current Symbol
NASDAQ:SYRA
Previous Symbol
NASDAQ:SYRA
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,940,000.00
Pretax Margin
-54.90%

Debt

Sales & Book Value

Annual Sales
$7.98 million
Price / Cash Flow
N/A
Book Value
$0.62 per share
Price / Book
0.49

Miscellaneous

Free Float
10,156,000
Market Cap
$3.47 million
Optionable
Not Optionable
Beta
3.20
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:SYRA) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners